A Case of Antiphospholipid Syndrome Refractory to Secondary Anticoagulating Prophylaxis after Deep Vein Thrombosis-Pulmonary Embolism / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 274-278, 2014.
Artículo
en Inglés
| WPRIM
| ID: wpr-159750
ABSTRACT
Antiphospholipid syndrome (APS) is an acquired systemic autoimmune disorder characterized by a combination of clinical criteria, including vascular thrombosis or pregnancy morbidity and elevated antiphospholipid antibody titers. It is one of the causes of deep vein thrombosis and pulmonary embolism that can be critical due to the mortality risk. Overall recurrence of thromboembolism is very low with adequate anticoagulation prophylaxis. The most effective treatment to prevent recurrent thrombosis is long-term anticoagulation. We report on a 17-year-old male with APS, who manifested blue toe syndrome, deep vein thrombosis, pulmonary thromboembolism, and cerebral infarction despite adequate long-term anticoagulation therapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Embolia Pulmonar
/
Recurrencia
/
Tromboembolia
/
Trombosis
/
Venas
/
Infarto Cerebral
/
Trastornos Cerebrovasculares
/
Mortalidad
/
Síndrome Antifosfolípido
/
Anticuerpos Antifosfolípidos
Tipo de estudio:
Estudio pronóstico
Límite:
Adolescente
/
Humanos
/
Masculino
/
Embarazo
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS